Skip to Main Content

Paper Details

Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial.
European Heart Journal - Cardiovascular Pharmacotherapy
10
2020
AF, atrial fibrillation, bleeding, edoxaban, patients, stroke, systemic embolism, thromboembolic events, vitamin K, warfarin
Author NameAffiliation
Elliott M AntmanBrigham and Women's Hospital and Harvard Medical School
Robert P GiuglianoBrigham and Women's Hospital and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2